Listen in as our panelists, Michelle Hager, Chris Halstead, & Jake Harper discussed:
- outcomes from DEA listening session
- impacts from literature review on drug diversion in telehealth patients
- potential future regulatory options
Blue Cirrus Consulting
Premier Telehealth Consulting Services
